Displaying drugs 951 - 975 of 1931 in total
KF-0210
KF-0210 is a small molecule developed by Keythera Pharmaceuticals. It is being investigated for cancers.
Investigational
VK-0214
Investigational
ATU-027
Atu027 has been used in trials studying the treatment of Advanced Solid Tumors.
Investigational
ETBX-021
Investigational
PLG-0206
PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections.
Investigational
Hydromethylthionine mesylate
Investigational
ASTX-029
ASTX-029 is under investigation in clinical trial NCT03520075 (Study of ASTX029 in Subjects With Advanced Solid Tumors).
Investigational
GLPG-0259
GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability and Food Effect).
Investigational
PM02734
PM02734 is a marine derived compound. PM02734 as a new antiproliferative drug demonstrating activity against a broad spectrum of tumor types: breast, colon, pancreas, lung and prostate, among others.
Investigational
VP025
VP025, a novel drug formulation based on phospholipid microparticles incorporating phosphatidylglycerol, can inhibit neuroinflammation. VP025 may inhibit immune system activation and protect motoneurons from injury. It also shows the ability to reduce inflammation across the blood-brain barrier and improve correlates of memory and learning function. It is being developed to...
Investigational
Sirna-027
Sirna-027 is a chemically modified short interfering RNA(siRNA) targeting Vascular Endothelial Growth Factor Receptor-1(VEGFR-1). VEGFR-1 is a key component of the clinically validated vascular endothelial growth factor (VEGF) pathway. Sirna-027 is developed by Sirna Therapeutics and is under the phase I of clinical trails. It is used to treat Macular...
Investigational
CTCE-0214
CTCE-0214 is a stable peptide agonist of stromal cell-derived factor-1 (SDF-1), a key signaling molecule in the proliferation, homing, engraftment and expansion of hematopoietic stem cells and white blood cells.
Investigational
VPO-227
Investigational
Matched Iupac: … -bromofuran-2-yl)-12,14-dimethyl-13,15-dioxo-17-phenyl-8-oxa-1,12,14-triazatetracyclo[8.7.0.0^{2,7}.0^ …
PD-0299685
PD-0299685 is under investigation in clinical trial NCT00314964 (Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause).
Investigational
Zamerovimab
Investigational
Otilonium
Experimental
Investigational
Matched Salts cas: … 26095-59-0 …
Matched Mixtures name: … SIMFLAT 40MG/80 MG FİLM KAPLI TABLET, 90 ADET ... DOLOSPAS 40 MG/80 MG FİLM KAPLI TABLET, 90 ADET …
Matched Products: … EKSPAZ 40 MG FILM TABLET, 90 ADET ... SPADIS 40 MG TABLET, 90 ADET ... PENSOTIL 40 MG FILM TABLET,90 ADET …
Matched Mixtures name: … SIMFLAT 40MG/80 MG FİLM KAPLI TABLET, 90 ADET ... DOLOSPAS 40 MG/80 MG FİLM KAPLI TABLET, 90 ADET …
Matched Products: … EKSPAZ 40 MG FILM TABLET, 90 ADET ... SPADIS 40 MG TABLET, 90 ADET ... PENSOTIL 40 MG FILM TABLET,90 ADET …
Pranlukast
Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.
Investigational
Matched Products: … PRANLUX 100 MG SAŞE, 90 SAŞE ... PRANLUX 50 MG SAŞE, 90 SAŞE ... PRANLUX 70 MG SAŞE, 90 SAŞE …
Mazorelvimab
Investigational
Ferritarg P
Investigational
Urapidil
Urapidil has been investigated for the treatment of Hypertension During Pre-Eclampsia.
Investigational
Matched Products: … EBRANTIL 90 ... Galluper 90 mg Hartkapseln, retardiert ... Uragelan 90 mg-Hartkapseln, retardiert …
Voglibose
Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with diabetes mellitus. It is made in India by Ranbaxy Labs and sold under the trade name Volix.
Investigational
Matched Products: … DIAVOG 0,2 MG EFERVESAN TABLET, 90 ADET ... DIAVOG 0,3 MG EFERVESAN TABLET, 90 ADET …
Displaying drugs 951 - 975 of 1931 in total